UA91697C2 - 3, 5-DISUBSTITUTED AND 3,5,7-TRISUBSTITUTED-3H-OXAZOLO AND 3H-THIAZOLO [4,5-d]PYRIMIDIN-2-ONE COMPOUNDS AND PRODRUGS THEREOF - Google Patents

3, 5-DISUBSTITUTED AND 3,5,7-TRISUBSTITUTED-3H-OXAZOLO AND 3H-THIAZOLO [4,5-d]PYRIMIDIN-2-ONE COMPOUNDS AND PRODRUGS THEREOF

Info

Publication number
UA91697C2
UA91697C2 UAA200708606A UAA200708606A UA91697C2 UA 91697 C2 UA91697 C2 UA 91697C2 UA A200708606 A UAA200708606 A UA A200708606A UA A200708606 A UAA200708606 A UA A200708606A UA 91697 C2 UA91697 C2 UA 91697C2
Authority
UA
Ukraine
Prior art keywords
compounds
prodrugs
oxazolo
thiazolo
trisubstituted
Prior art date
Application number
UAA200708606A
Other languages
Russian (ru)
Inventor
Стивен И. Уеббер
Грегори Дж. Хейли
Джозеф Ар. Леннокс
Алан Ксин Сианг
Эрик Дж. Руден
Original Assignee
Анадис Фармасьютикалз, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Анадис Фармасьютикалз, Инк. filed Critical Анадис Фармасьютикалз, Инк.
Priority claimed from PCT/US2005/045589 external-priority patent/WO2006066080A1/en
Publication of UA91697C2 publication Critical patent/UA91697C2/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

The invention is directed to 3,5-disubstituted and 3,5,7-trisubstituted-3-H-oxazolo and 3H-thiazolo[4,5-d]pyrimidin-2-one compounds and prodrugs thereof that have immunomodulatory activity. The invention is also directed to the therapeutic or prophylactic use of such compounds and pharmaceutical compositions containing them, and to methods of treating diseases and disorders described herein, by administering effective amounts of such compounds and prodrugs.
UAA200708606A 2004-12-17 2005-12-16 3, 5-DISUBSTITUTED AND 3,5,7-TRISUBSTITUTED-3H-OXAZOLO AND 3H-THIAZOLO [4,5-d]PYRIMIDIN-2-ONE COMPOUNDS AND PRODRUGS THEREOF UA91697C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63663304P 2004-12-17 2004-12-17
PCT/US2005/045589 WO2006066080A1 (en) 2004-12-17 2005-12-16 3, 5-DISUBSTITUTED AND 3,5,7-TRISUBSTITUTED-3H-OXAZOLO AND 3H-THIAZOLO [4,5-d]PYRIMIDIN-2-ONE COMPOUNDS AND PRODRUGS THEREOF

Publications (1)

Publication Number Publication Date
UA91697C2 true UA91697C2 (en) 2010-08-25

Family

ID=52011546

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200708606A UA91697C2 (en) 2004-12-17 2005-12-16 3, 5-DISUBSTITUTED AND 3,5,7-TRISUBSTITUTED-3H-OXAZOLO AND 3H-THIAZOLO [4,5-d]PYRIMIDIN-2-ONE COMPOUNDS AND PRODRUGS THEREOF

Country Status (1)

Country Link
UA (1) UA91697C2 (en)

Similar Documents

Publication Publication Date Title
TNSN07208A1 (en) 3,5-DISUBTITUTED AND 3,5,7-TRISUBSTITUTED-3H-OXAZOLO AND 3H-THIAZOLO [4,5-d] PYRIMIDIN-2-ONE COMPOUNDS AND PRODRUGS THEREOF
TNSN06403A1 (en) 3-B-D-RIBOFURANOSYLTHIAZOLO[4,5-d]PYRIDIMINE NUCLEOSIDES AND USES THEREOF
MXPA04004966A (en) 3-beta-D-RIBOFURANOSYLTHIAZOLO[4,5-d.
TW200608979A (en) Pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
TW200800976A (en) New compounds for the treatment of neurological, psychiatric or pain disorders
WO2006113864A3 (en) Oxindole compounds and their uses as therapeutic agents
TW200724543A (en) Heterocyclic compounds and their uses as therapeutic agents
WO2003096990A3 (en) Protein cages for the delivery of medical imaging and therapy
WO2004062625A3 (en) Macrocyclic beta-secretase inhibitors for treatment of alzheimer's disease
HK1092467A1 (en) N-alkyl-hydroxamic acid-isoindolyl compounds and their pharmaceutical uses n-
WO2005004803A3 (en) Phenylcarboxylate beta-secretase inhibitors for the treatment of alzheimer's disease
WO2007100366A3 (en) Quinolone m1 receptor positive allosteric modulators
TW200611695A (en) Pyrrolopyridine derivatives
WO2007064932A3 (en) Pyrrolotriazine derivatives useful for treating cancer through inhibition of aurora kinase
GB0222495D0 (en) Compounds
GB0225475D0 (en) Therapeutic agents
WO2005018545A3 (en) Macrocyclic beta-secretase inhibitors for the treatment of alzheimer's disease
TW200628473A (en) Novel heterocycles
WO2004074243A3 (en) Heterocyclyl-3-sulfonylindazoles as 5-hydroxytryptamine-6 ligands
MY141528A (en) Anilinopyrazole derivatives useful for the treatment of diabetes
WO2002079169A8 (en) Cyano-substituted dihydropyrimidine compounds and their use to treat diseases
WO2002079149A3 (en) Novel cyano-substituted dihydropyrimidine compounds and their use to treat diseases
AU2003260436A1 (en) Pyrimidine compounds
WO2005016272A3 (en) Aryl, heteroaromatic and bicyclic aryl nitrone compounds, prodrugs and pharmaceutical compositions of the same to treat human disorders
UA91697C2 (en) 3, 5-DISUBSTITUTED AND 3,5,7-TRISUBSTITUTED-3H-OXAZOLO AND 3H-THIAZOLO [4,5-d]PYRIMIDIN-2-ONE COMPOUNDS AND PRODRUGS THEREOF